Urinary cytokine profiles according to the site of blockade of the renin-angiotensin system in nephrectomized rats / Perfil de citocinas urinárias de acordo com o local de bloqueio do sistema renina angiotensina em ratos nefrectomizados

Abstract Introduction: It is still unknown how the pharmacological inhibition of the Renin Angiotensin System (RAS) impacts the levels of inflammation and fibrosis biomarkers. Objective: This study sought to evaluate the effect of enalapril, candesartan and aliskiren on urinary levels of cytokines in a model of chronic kidney disease (CKD). Methods: Male Wistar rats were submitted to surgical removal of ¾ of renal parenchyma to induce CKD (¾ nephrectomy), or subjected to sham surgery (control). Animals were then randomized into five groups: Sham surgery receiving vehicle; ¾ Nephrectomy receiving vehicle; ¾ Nephrectomy receiving enalapril (10 mg/kg); ¾ Nephrectomy receiving candesartan (10 mg/kg) and ¾ Nephrectomy receiving aliskiren (10 mg/kg). Urine output, water intake, mean arterial pressure (MAP) and urinary concentrations of creatinine, urea, albuminuria, Na+, K+, interleukin (IL) -1β, IL-6, IL-10 and transforming growth factor beta (TGF-β) were measured. Results: Nephrectomy significantly impaired renal function, increased MAP and altered the levels of all evaluated cytokines in urine. Enalapril, candesartan and aliskiren improved renal function and decreased MAP and IL-6 when compared to vehicle-treated nephrectomized group. Candesartan and aliskiren decreased IL-1β, while only candesartan reduced TGF-β and only aliskiren increased IL-10. Conclusion: Enalapril, candesartan and aliskiren presented similar effects on improving renal function and reducing MAP and urinary levels of IL-6 in rats with CKD. On the other hand, cytokine profile differed according to the treatment, suggesting that differential mechanisms were triggered in response to the site of RAS blockade.

Resumo Introdução: Ainda não se sabe como a inibição farmacológica do Sistema Renina Angiotensina (SRA) afeta os níveis de biomarcadores de inflamação e fibrose. Objetivo: Este estudo pretendeu avaliar o efeito de enalapril, candesartan e alisquireno sobre os níveis urinários de citocinas em um modelo de doença renal crônica (DRC). Métodos: Ratos Wistar machos foram submetidos à remoção cirúrgica de ¾ do parênquima renal para induzir DRC (nefrectomia), ou submetidos à cirurgia fictícia (controle). Animais foram então randomizados em cinco grupos: Cirurgia fictícia recebendo veículo; Nefrectomia recebendo veículo; Nefrectomia recebendo enalapril (10 mg/kg); Nefrectomia recebendo candesartan (10 mg/kg) e Nefrectomia recebendo alisquireno (10 mg/kg). Débito urinário, ingesta hídrica, pressão arterial media (PAM) e concentrações urinárias de creatinina, ureia, albumina, Na+, K+, interleucina (IL) -1β, IL-6, IL-10 e fator de transformação e crescimento beta (TGF-β) foram medidas. Resultados: A nefrectomia comprometeu significativamente a função renal, aumentou a PAM e alterou os níveis de todas as citocinas avaliadas na urina. Enalapril, candesartan e alisquireno melhoraram a função renal e diminuíram a PAM e a IL-6 quando comparado aos grupo de animais nefrectomizados tratados com veículo. Candesartan e alisquireno reduziram IL-1β, enquanto somente candesartan diminuiu o TGF-β e somente alisquireno aumentou a IL-10. Conclusão: Enalapril, candesartan e alisquireno apresentaram efeitos similares em relação à melhora da função renal e redução da PAM e dos níveis urinários de IL-6 em ratos com DRC. Por outro lado, o perfil de citocinas diferiu de acordo com o tratamento, sugerindo que diferentes mecanismos sejam desencadeados em resposta ao local de bloqueio do SRA.

Efeitos do trabalho noturno nos ritmos circadianos de marcadores do processo inflamatório / Effects of night work on circadian rhythms of markers of inflammation

Introdução: Uma das reconhecidas consequências do trabalho noturno nos trabalhadores é a perda da ordem temporal interna, a qual resulta em alterações fisiopatológicas. Objetivo: O presente estudo teve o objetivo de avaliar os efeitos do turno noturno de traballho na concentração e no ritmo circadiano de citocinas inflamatórias de trabalhadores de linha de produção e operadores de máquinas. Material e Métodos: Estudo transversal realizado em uma empresa do setor de bebidas. Na Etapa 1 foram avaliados em 123 trabalhadores (56 do turno fixo diurno e 67 do turno fixo noturno), dados sociodemográficos, condições de vida e lazer, condições e organização do trabalho, morbidades, sintomas osteomusculares, fadiga, sonolência excessiva e dados antropométricos. Quinze voluntários do turno diurno, 15 do turno noturno em período de trabalho e em momento de férias participaram da Etapa 2. Durante sete dias foram coletados dados do padrão de sono e vigília e em um Dia de Trabalho e um Dia de Folga foram realizadas coletas salivares em intervalos de três horas, durante a vigília, para estimar a concentração de melatonina, IL-1 e IL-6, além de coletados dados de sonolência, fadiga e dor. Também foi realizada coleta de urina para medir 6-sulfatoximelatonina após o episódio principal de sono. Foram verificadas diferenças de médias entre os dados dos grupos obtidos na Etapa 1, assim como análises de Odds Ratio...

Introduction: A recognized consequence of night shift work on employees is the loss of internal temporal order, which results in pathophysiological alterations. Objective: This study aimed to evaluate the effects of night shift work on the level and circadian rhythm of inflammatory cytokines of line workers and machine operators. Methods: A cross-sectional study was conducted in a beverage company. On stage 1 of the study, demographic data, living and leisure conditions, work conditions and organization, morbidity, musculoskeletal symptoms, fatigue, excessive sleepiness and anthropometric data of 123 workers (56 fixed day workers and 67 fixed night shift workers) were evaluated. Fifteen volunteers from day shift, 15 from night shift, and 15 from the same night shift during vacation participated in stage 2. During seven consecutive days, data were collected regarding the pattern of sleep and wakefulness. Also, on one work day and one day off, within this 7 days, saliva samples were collected every three hours while subjects were awake to evaluate melatonin, IL-1 and IL-6, in addition to drowsiness, fatigue and pain data were also collected. Furthermore, urine samples were collected to measure 6-sulphatoxymelatonin after the main sleep episode. Mean differences between groups and analysis of Odds Ratio were used to evaluate the data collected on stage 1...

Role of urinary biomarkers in the diagnosis of congenital upper urinary tract obstruction

Congenital obstructive uropathy constitutes a significant cause of morbidity in children. Currently, there is no reference standard for the diagnosis of renal obstruction in children. The con-invasive measurement of biomarkers in voided urine has considerable appeal as a potential application in children with congenital obstructive nephropathy. The aim of the present review is to explore the current role of biomarkers in the diagnosis and follow-up of obstructive uropathy in children. The literature data [PubMed] was scarched from inception to May 2007, regarding the role of urinary biomarkers in the diagnosis and follow-up of children with congenital obstructive uropathy. The review included 23 experimental and 33 prospective controlled clinical studies. Several cytokines, peptides, enzymes and microproteins were indentified as major contributors to, or as biomarkers ensuing from obstruction-induced renal fibrosis and apoptosis. The most important biomarkers were transforming growth factor-beta1 [TGF- beta1], epidermal growth factor [EGF], endothelin-1 [ET-1], urinary tubular enzymes [N-acetyI- beta-D-glucosaminidase [NAG], gamma-glutamyI transferase [GGT] and alkaline phosphatase [ALP]], and microproteins [beta2-microglobulin [beta2M], microalbumin [M.AIb] and micrototal protein [M.TP]. All biomarkers showed different degrees of success but the most promising markers were TGF- betaI, ET-I and a panel of tubular enzymes. These biomarkers showed a sensitivity of 74.3% to 100%, a specifity of 80% to 90% and an overall accuracy of 81.5% to 94% in the diagnosis of congenital obstructive uropathy in children. Moreover, come of the markers were valuable in differentiation between dilated non-obstructed kidneys qualifying for conservative management and obstructed kidneys requiring surgical correction. Some studies demonstrated that urinaty biomarkers are helfpul in evaluating the success of treatment in children with congenital renal obstruction. Some limitations of the previous studies include lack of controls and small sample size. Larger controlled studies are necessary to confirm the clinical usefulness of biomarkers in the diagnosis and follow-up of children with congenital obstructive uropathy. Urinary biomarkers are a promising tool that could be used as a non-invasive assessment of congenital renal obstruction in children

Estimation of serum and urinary profibrotic cytokines in renal allograft recipients

In this study, serum and urinary transforming growth factor beta 1 [TGF- beta 1] and platelet derived growth factor [PDGF] levels were determined by enzyme-linked immunosorbent assay [ELISA] in ten renal allograft recipients for more than one year with normal renal function [group I], ten renal allograft recipients for more than one year with impaired renal function [group II] and ten patients with chronic renal failure [CRF] under conservative therapy [group III] and the measurements were compared with the levels of ten healthy controls [group IV]. The data confirmed the crucial contribution of the profibrotic cytokines TGF-beta 1 and PDGF in the development of chronic graft dysfunction that could be further augmented by cyclosporine A therapy. Further studies are needed to examine the effect of manipulation of immunosuppressive regimen on the extent of profibrotic gene expression as well as the long-term graft survival